Congenital Cytomegalovirus Infection: Clinical Outcome | Zendy

Suresh B. Boppana | Zendy; Shan Ross | Zendy; Karen B. Fowler | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Congenital Cytomegalovirus Infection: Clinical Outcome

Author(s) -

Suresh B. Boppana,

Shan Ross,

Karen B. Fowler

Publication year - 2013

Publication title -

clinical infectious diseases

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cit629

Subject(s) - medicine , asymptomatic , cytomegalovirus , pediatrics , human cytomegalovirus , cytomegalovirus infections , betaherpesvirinae , intensive care medicine , immunology , herpesviridae , viral disease , surgery , virus

Congenital cytomegalovirus (CMV) infection is a leading cause of hearing loss and neurologic disabilities in children worldwide. Infants with symptomatic congenital CMV infection at birth are at significantly increased risk for developing adverse long-term outcomes. The vast majority of infants with congenital CMV infection have no clinical findings at birth (asymptomatic infants), and about 10%-15% of these children develop long-term sequelae. Currently, predictors of adverse outcome in asymptomatic congenital CMV infection are not known, and it is important that future studies address this issue.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research